Morepen Laboratories Ltd (MORL.BO)
MORL.BO on Bombay Stock Exchange
2.70INR
3:01pm IST
2.70INR
3:01pm IST
Price Change (% chg)
Rs-0.03 (-1.10%)
Rs-0.03 (-1.10%)
Prev Close
Rs2.85
Rs2.85
Open
Rs2.61
Rs2.61
Day's High
Rs2.75
Rs2.75
Day's Low
Rs2.61
Rs2.61
Volume
35,860
35,860
Avg. Vol
51,863
51,863
52-wk High
Rs4.69
Rs4.69
52-wk Low
Rs2.46
Rs2.46
MORL.BO
About
Morepen Laboratories Limited is a holding company. The Company is engaged in manufacture and commercialization of active pharma ingredients (API) and intermediates for the markets of the United Sates, Canada and Europe. Claritin is the Company’s anti-allergy drug Loratidine. The formulations division includes Medicus and... (more)
No analyst recommendations are available for MORL.BO.
Overall
| Beta: | 1.32 |
| Market Cap (Mil.): | Rs1,214.53 |
| Shares Outstanding (Mil.): | 449.83 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| MORL.BO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 35.67 | 35.85 |
| EPS (TTM): | -0.79 | -- | -- |
| ROI: | -- | 19.40 | 18.76 |
| ROE: | -- | 20.11 | 19.57 |
Earnings vs. 
Estimates
No consensus analysis data available.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
